Novotech Releases Hepatitis B Global Clinical Trial Landscape Report 2025
Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics, has released its latest disease report: Hepatitis B - Global Clinical Trial Landscape (2025). The report provides a comprehensive analysis of global trends, challenges, and emerging opportunities in the Hepatitis B clinical research ecosystem.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250306591902/en/
The report leverages Novotech’s extensive experience and offers valuable insights for biotech companies, healthcare professionals, and stakeholders engaged in Hepatitis B research, featuring:
- Epidemiology Overview: Insights into the global burden of Hepatitis B, with a detailed focus on high-prevalence regions including Asia-Pacific and Africa.
- Clinical Trial Landscape: Analysis of over 100 industry-sponsored trials globally, with Asia-Pacific leading in trial density and innovation. Novotech has managed 90 trials in the region, with Australia hosting 79. Additional contributions from Hong Kong, Taiwan, New Zealand, South Korea, and Thailand reinforce the region’s role in advancing Hepatitis B research.
- Drug Pipeline Innovations: Exploration of advanced therapeutic modalities, including RNA-based therapies, antisense oligonucleotides, monoclonal antibodies, and therapeutic vaccines.
- Biomarkers and Clinical Endpoints: A guide to emerging biomarkers such as HBV RNA and HBcrAg, and their role in optimizing clinical outcomes and trial designs.
The report highlights a 31.95% CAGR in Hepatitis B trials from 2020 to 2024, driven by advances in small molecules, siRNA therapies, and therapeutic vaccines. Novotech is the global leader in hepatitis B research, having supported 90 Hepatitis B trials and counting, initiating 340+ sites and enrolling 5,000+ participants across all trial phases, including 65 Phase I and 25 Phase II studies. With experience in diverse therapeutic modalities such as small molecules, antisense RNAi oligonucleotides, monoclonal antibodies, vaccines, proteins, and peptides.
The Hepatitis B - Global Clinical Trial Landscape (2025) report is now available for download. Gain actionable insights to guide your clinical development strategies and optimize trial execution.
About Novotech Novotech-CRO.com
Novotech is a globally recognized full-service clinical research organization (CRO) and scientific advisory company that provides biotech and small- to mid-sized pharma companies an accelerated path to market since 1997. With a global footprint spanning 30+ offices across the Asia-Pacific region, North America, and Europe, and partnerships with 5,000+ trial sites, Novotech offers unparalleled access to key clinical trial destinations and diverse patient populations.
Novotech leverages its therapeutic and regulatory expertise, client-centric service model, local market insights, and advanced analytical tools to expedite patient recruitment, enhance trial efficiencies, and bring life-changing therapies to market faster. This work has been recognized by awards such as the Frost & Sullivan CRO Company of the Year, which Novotech has received for 19 consecutive years.
For more information or to speak to an expert team member visit www.Novotech-CRO.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20250306591902/en/
Contacts
Media
Toyna Chin
mediacontact@novotech-cro.com
USA: +1 415 364 8135
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Venture Global Announces Major Brownfield Expansion of Plaquemines LNG6.3.2025 20:30:00 EET | Press release
Today, Venture Global (NYSE: VG) announced plans for a brownfield expansion at its Plaquemines LNG facility south of New Orleans, Louisiana. Joining Venture Global for the announcement was Secretary of Energy Chris Wright, Secretary of the Interior Doug Burgum, Louisiana Governor Jeff Landry and other federal, state and local officials and stakeholders. The planned Plaquemines expansion will consist of 24 trains and would represent an approximately $18 billion additional investment in the State of Louisiana, bringing Venture Global’s total investment in our current and planned US projects to over $75 billion. Plaquemines LNG, approved during President Trump’s first term, is the newest LNG export facility to come online in the United States and is expected to produce approximately 27 million tonnes per annum (MTPA). Today, Venture Global is announcing that it will expand that capacity by over 18 MTPA, bringing the expected total production capacity to over 45 MTPA at Plaquemines. “Our p
DDS Wireless Launches Scheduled Routes: A Powerful Routing & Scheduling Optimization Solution6.3.2025 20:17:00 EET | Press release
DDS Wireless, a global leader in fleet management technology, has officially launched Scheduled Routes, an advanced Routing & Scheduling Optimization solution designed to help businesses improve fleet efficiency, reduce costs, and enhance service reliability. With the ability to process up to 50,000 stops per call—ten times the industry standard—Scheduled Routes delivers a next-generation approach to fleet optimization. Leveraging cutting-edge algorithms, the solution dynamically adjusts routes based on capacity, time windows, vehicle availability, and real-time traffic conditions. This results in greater efficiency, reduced costs, and improved service reliability at scale. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250305795793/en/ "Scheduled Routes is ready to help businesses transform their operations today," said Jason Piippo, VP of Sales at DDS Wireless. "Our solution delivers immediate value by cutting costs, incre
Thredd Releases Expert Guide Addressing the Need for Greater Transparency and Control in Financial Programmes6.3.2025 17:04:00 EET | Press release
Thredd, a leading next-generation global payments processor, today released Payments Unstitched: Protecting & Growing Your Payments Business in 2025 providing fintechs, financial institutions, bank sponsors and others insights into the challenges impacting sustainable growth. "Today, speed to market and rapid innovation cycles continue to drive us forward, but succeeding in the next chapter of financial transformation will require focusing on a new set of challenges," said Jim McCarthy, CEO of Thredd. "This guide aims to capture some of the expert insights players in our ecosystem can use to address key trends and protect and grow their businesses." The guide focuses on three broad sets of business challenges and potential remedies and tools for effectively addressing them: Vital operational controls that are labour-intensive, costly and subject to error. Continuously evolving fraud and risk challenges. A regulatory and business environment placing more burden and scrutiny on complianc
Armis Acquires OTORIO to Expand its Leadership in Operational Technology and Cyber-Physical Security6.3.2025 17:00:00 EET | Press release
Armis, the cyber exposure management & security company, announced today that it has acquired OTORIO, a leading provider of OT (Operational Technology) and CPS (Cyber Physical Systems) security. OTORIO’s Titan platform will be integrated into Armis’ Centrix™ cloud-based cyber exposure management platform to expand Armis’ OT/CPS suite and offer an on-premises CPS solution for organizations or segments of an organization’s environment that are airgapped or sequestered from online access. “We are seeing unprecedented demand across all industries but for some specific verticals, customers require a hybrid environment for complete protection. Through this acquisition, Armis can now offer an on-premises solution for customers that require a fully air-gapped environment for heavy industry and critical infrastructure like energy or utilities,” said Yevgeny Dibrov, CEO and Co-founder, Armis. “I am excited to welcome the OTORIO team to Armis and leveraging their expertise and deep foundational i
Introducing Spinnaker Cloud Managed Services: Empowering Organizations to Modernize on Their Own Terms and Timeline6.3.2025 16:00:00 EET | Press release
Spinnaker Support (Spinnaker), trusted by companies worldwide to support their essential Oracle, SAP, and VMware software, today introduces Spinnaker Cloud Managed Services--a new offering that allows organizations to actualize its cloud strategy without having to move away from the legacy system(s) their business is built upon. Spinnaker Cloud Managed Services supports Oracle and SAP, environments across both legacy and cloud platforms, delivering a high-touch service with expert management. Trusted by over a thousand companies worldwide to provide third-party software support for Oracle, SAP, and VMware, Spinnaker’s new Cloud Managed Services offering fulfils a critical need for organizations looking to move to the cloud--and with Spinnaker, they can do so at their own pace without being locked into vendor demands. Spinnaker’s Cloud Managed Services offering enables organizations to: Move to the cloud: Without having to move away from legacy products. Take control: Spinnaker puts org
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom